DE3854495D1 - Tetrapyrrolaminocarbonsäuren. - Google Patents

Tetrapyrrolaminocarbonsäuren.

Info

Publication number
DE3854495D1
DE3854495D1 DE3854495T DE3854495T DE3854495D1 DE 3854495 D1 DE3854495 D1 DE 3854495D1 DE 3854495 T DE3854495 T DE 3854495T DE 3854495 T DE3854495 T DE 3854495T DE 3854495 D1 DE3854495 D1 DE 3854495D1
Authority
DE
Germany
Prior art keywords
tetrapyrrolaminocarboxylic
acids
tetrapyrrolaminocarboxylic acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE3854495T
Other languages
English (en)
Other versions
DE3854495T2 (de
Inventor
Jerry C Bommer
Bruce F Burnham
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eneos Corp
Original Assignee
Nippon Petrochemicals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Petrochemicals Co Ltd filed Critical Nippon Petrochemicals Co Ltd
Application granted granted Critical
Publication of DE3854495D1 publication Critical patent/DE3854495D1/de
Publication of DE3854495T2 publication Critical patent/DE3854495T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/001Preparation for luminescence or biological staining
    • A61K49/0013Luminescence
    • A61K49/0017Fluorescence in vivo
    • A61K49/0019Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0036Porphyrins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/001Preparation for luminescence or biological staining
    • A61K49/0013Luminescence
    • A61K49/0017Fluorescence in vivo
    • A61K49/005Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0052Small organic molecules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE3854495T 1987-12-24 1988-12-23 Tetrapyrrolaminocarbonsäuren. Expired - Lifetime DE3854495T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/137,750 US5004811A (en) 1987-12-24 1987-12-24 Tetrapyrrole aminocarboxylic acids

Publications (2)

Publication Number Publication Date
DE3854495D1 true DE3854495D1 (de) 1995-10-26
DE3854495T2 DE3854495T2 (de) 1996-03-28

Family

ID=22478892

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3854495T Expired - Lifetime DE3854495T2 (de) 1987-12-24 1988-12-23 Tetrapyrrolaminocarbonsäuren.

Country Status (6)

Country Link
US (1) US5004811A (de)
EP (1) EP0322795B1 (de)
JP (1) JPH0753733B2 (de)
AU (1) AU618054B2 (de)
CA (1) CA1340023C (de)
DE (1) DE3854495T2 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3827940A1 (de) * 1988-08-13 1990-03-01 Schering Ag 13,17-propionsaeure- und propionsaeurederivat- substituierte porphyrin-komplexverbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
US5759837A (en) * 1989-01-17 1998-06-02 John Hopkins University Chemotherapy for cancer by inhibiting the fatty acid biosynthetic pathway
US20020058008A1 (en) * 1989-07-28 2002-05-16 Kennedy James C. Photochemotherapeutic method using 5-aminolevulinic acid and other precursors of endogenous porphyrins
US5955490A (en) * 1989-07-28 1999-09-21 Queen's University At Kingston Photochemotherapeutic method using 5-aminolevulinic acid and other precursors of endogenous porphyrins
US6710066B2 (en) 1989-07-28 2004-03-23 Queen's University At Kingston Photochemotherapeutic method using 5-aminolevulinic acid and other precursors of endogenous porphyrins
US5234940A (en) * 1989-07-28 1993-08-10 Queen's University Photochemotherapeutic method using 5-aminolevulinic acid and precursors thereof
JP3154742B2 (ja) * 1991-04-30 2001-04-09 日本石油化学株式会社 哺乳類の動脈硬化症治療剤
US20040110819A1 (en) * 1991-10-28 2004-06-10 Queen's University At Kingston Photochemotherapeutic method using 5-aminolevulinic acid and other precursors of endogenous porphyrins
JP3565442B2 (ja) * 1993-04-22 2004-09-15 新日本石油化学株式会社 哺乳類の関節炎の診断剤および/または治療剤
US5492924A (en) * 1993-09-24 1996-02-20 Fox Chase Cancer Center Phorbine derivatives and their use in the diagnosis and therapy of cancer
WO2000000204A1 (en) 1997-02-14 2000-01-06 Miravant Pharmaceuticals, Inc. Indium photosensitizers for pdt
AU2504900A (en) * 1999-01-15 2000-08-01 Light Sciences Corporation Therapeutic compositions for metabolic bone disorders or bone metastases
US20030114434A1 (en) * 1999-08-31 2003-06-19 James Chen Extended duration light activated cancer therapy
US7897140B2 (en) 1999-12-23 2011-03-01 Health Research, Inc. Multi DTPA conjugated tetrapyrollic compounds for phototherapeutic contrast agents
AU2001277059A1 (en) * 2000-07-21 2002-02-05 North Carolina State University Trans beta substituted chlorins and methods of making and using the same
US6765092B2 (en) 2000-07-21 2004-07-20 North Carolina State University Regioisomerically pure oxochlorins and methods of synthesis
US6559374B2 (en) 2000-07-21 2003-05-06 North Carolina State University Trans beta substituted chlorins and methods of making and using the same
WO2002013820A1 (en) * 2000-08-11 2002-02-21 Ceramoptec Industries, Inc. Photosensitizing ointment
GB0023367D0 (en) * 2000-09-23 2000-11-08 Univ Leeds Photosensitisers
DK1364044T3 (da) * 2000-11-17 2012-05-07 Biomoda Inc Sammensætninger og fremgangsmåder til påvisning af præcancerøse tilstande i celle- og vævsprøver under anvendelse af 5,10,15,20-tetrakis(carboxyphenyl)porphin
US6849730B2 (en) 2001-09-25 2005-02-01 North Carolina State University Methods of making porphyrins and related compounds with Lewis acids
EP1467760A2 (de) * 2002-01-23 2004-10-20 Light Sciences Corporation Systeme und verfahren zur photodynamischen therapie
CA2490692A1 (en) 2002-06-27 2004-01-08 Health Research, Inc. Fluorinated chlorin and bacteriochlorin photosensitizers for photodynamic therapy
WO2004005289A2 (en) 2002-07-02 2004-01-15 Health Research, Inc. Efficient synthesis of pyropheophorbide a and its derivatives
IL152900A0 (en) * 2002-11-17 2003-06-24 Yeda Res & Dev Water-soluble bacteriochlorophyll derivatives and their pharmaceutical uses
US10376711B2 (en) * 2003-03-14 2019-08-13 Light Sciences Oncology Inc. Light generating guide wire for intravascular use
CN2885311Y (zh) 2006-01-18 2007-04-04 郑成福 经尿道光动力疗法前列腺治疗仪
US20080269846A1 (en) * 2003-03-14 2008-10-30 Light Sciences Oncology, Inc. Device for treatment of blood vessels using light
US7884280B2 (en) * 2003-05-27 2011-02-08 North Carolina State University Stepwise fabrication of molecular-based, cross linked, light harvesting arrays
AU2003292591A1 (en) * 2003-06-20 2005-01-04 Keio University Photodynamic therapy apparatus, method for controlling photodynamic therapy apparatus, and photodynamic therapy method
US7323561B2 (en) * 2004-12-23 2008-01-29 North Carolina State University Metal complexation of 1-acyldipyrromethanes and porphyrins formed therefrom
US20080070971A1 (en) * 2006-03-06 2008-03-20 Wang Xiang H Medical Use of Bilirubin and its Structural Analogues
WO2011009137A1 (en) 2009-07-17 2011-01-20 Biomoda, Inc. System and method for analyzing samples labeled with 5, 10, 15, 20 tetrakis (4-carboxyphenyl) porphine (tcpp)
WO2011105631A1 (ja) 2010-02-26 2011-09-01 学校法人慶應義塾 光化学反応により心筋組織の光線力学的アブレーションを行うカテーテル
WO2014071138A1 (en) 2012-11-02 2014-05-08 Lewis Thomas J Disease detection and treatment through activation of compounds using external energy
MX2018015916A (es) 2016-06-16 2019-03-28 Oncoselect Therapeutics Llc Compuestos de porfirina y composiciones útiles para el tratamiento de cáncer.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4649151A (en) * 1982-09-27 1987-03-10 Health Research, Inc. Drugs comprising porphyrins
US4675338A (en) * 1984-07-18 1987-06-23 Nippon Petrochemicals Co., Ltd. Tetrapyrrole therapeutic agents
US4693885A (en) * 1984-07-18 1987-09-15 Nippon Petrochemicals Co., Ltd. Tetrapyrrole therapeutic agents
US4977177A (en) * 1985-04-30 1990-12-11 Nippon Petrochemicals Company, Ltd. Tetrapyrrole polyaminomonocarboxylic acid therapeutic agents
US4656186A (en) * 1985-04-30 1987-04-07 Nippon Petrochemicals Co., Ltd. Tetrapyrrole therapeutic agents
JPS625986A (ja) * 1985-04-30 1987-01-12 Nippon Petrochem Co Ltd 新規なテトラピロ−ル化合物
DE19931877A1 (de) * 1999-07-09 2001-01-11 Winterhalter Gastronom Gmbh Hebemechanismus

Also Published As

Publication number Publication date
DE3854495T2 (de) 1996-03-28
US5004811A (en) 1991-04-02
JPH0753733B2 (ja) 1995-06-07
EP0322795A3 (de) 1991-04-10
EP0322795B1 (de) 1995-09-20
EP0322795A2 (de) 1989-07-05
AU618054B2 (en) 1991-12-12
CA1340023C (en) 1998-09-01
JPH01294678A (ja) 1989-11-28
AU2768789A (en) 1989-06-29

Similar Documents

Publication Publication Date Title
DE3854495D1 (de) Tetrapyrrolaminocarbonsäuren.
FI901578A0 (fi) Implanterbar konstnjure.
DE3880632D1 (de) Kuevette.
DE3881291D1 (de) Sehapparat.
DE3862564D1 (de) Erdanker.
FI884011A0 (fi) Tobaksprodukter.
FI77952B (fi) Ljusbaogsrelae.
FI881087A (fi) Framstaellningsfoerfarande foer tiazepinfoerening.
DE3867976D1 (de) Polymergebundene antioxydationsmittel.
DE3883705D1 (de) Alkenylbicyclohexane.
DE3876873D1 (de) Weblitzenuebergabevorrichtung.
DE3785663D1 (de) Loetgeraet.
DE3876304D1 (de) Polysilacylobutasilazane.
DE3882446D1 (de) Polydisilacyclobutasilazane.
ATE90079T1 (de) Substituierte 2-phenyl-4-chinolincarbonsaeuren.
DE3870513D1 (de) Tennisball.
FI881548A0 (fi) Upphettbar glaensnings- eller kalandervals.
DE3888991D1 (de) Aminokohlenwasserstoff-substituierte Ketoximosilane.
FI77055B (fi) Vaermegradient-inkubator.
DE3879348D1 (de) Fm-cw-radargeraet.
DE3877421D1 (de) Polyamidbenzazole.
DE3878970D1 (de) Praeparative chromatographiesaeule.
DE3862309D1 (de) Aminomethyltetrahydrofurane.
ES2023228B3 (es) Ciclopropancarboxamidas.
DE3860710D1 (de) Exklusiv-oder-schaltung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: NIPPON OIL CORP., TOKIO/TOKYO, JP